Updated Jul 16, 2026
Chopra Daveen has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $573K.
Daveen Chopra is a corporate executive currently serving as the Chief Vice President (CVP) of Transcatheter Mitral and Tricuspid Therapies (TMTT) at Edwards Lifesciences Corp. His role involves overseeing surgical innovations and therapies related to heart valve treatments. Details about his previous professional background and education are not widely available.
| Role | CVP, TMTT & Surgical |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-22 | EW | Edwards Lifesciences Corp | S — Open-market sale | 1.5K | $84.60 | $127K |
| 2026-05-12 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 7.5K | $79.96 | $603K |
| 2026-05-12 | EW | Edwards Lifesciences Corp | M — Option exercise | 13.6K | $0.00 | |
| 2026-05-09 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 1.1K | $82.76 | $94K |
| 2026-05-09 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 674 | $83.20 | $56K |
| 2026-05-09 | EW | Edwards Lifesciences Corp | A — Grant or award | 9.7K | $0.00 | |
| 2026-05-04 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 282 | $83.98 | $24K |
| 2025-09-11 | EW | Edwards Lifesciences Corp | A — Grant or award | 3.2K | $0.00 | |
| 2025-08-25 | EW | Edwards Lifesciences Corp | S — Open-market sale | 2.5K | $81.95 | $205K |
| 2025-05-22 | EW | Edwards Lifesciences Corp | S — Open-market sale | 1.5K | $75.08 | $113K |
| 2025-05-11 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 580 | $73.68 | $43K |
| 2025-05-07 | EW | Edwards Lifesciences Corp | A — Grant or award | 9.2K | $0.00 | |
| 2025-05-07 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 627 | $74.92 | $47K |
| 2025-05-03 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 289 | $75.65 | $22K |
| 2025-05-03 | EW | Edwards Lifesciences Corp | F — Tax withholding / forfeiture | 291 | $75.65 | $22K |
| 2024-12-06 | EW | Edwards Lifesciences Corp | S — Open-market sale | 1.8K | $73.27 | $128K |
Daveen Chopra is a corporate executive currently serving as the Chief Vice President (CVP) of Transcatheter Mitral and Tricuspid Therapies (TMTT) at Edwards Lifesciences Corp. His role involves overseeing surgical innovations and therapies related to heart valve treatments. Details about his previous professional background and education are not widely available.…
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($573K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Chopra Daveen profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.